Wilhite et al. [68] reported that vulvar and vaginal melanomas showed a lower expression of adaptive immunity genes and a lower expression of PD-L1 ligands compared to cutaneous melanoma, which probably caused a worse prognosis after immunotherapy. The gene discussed is CD274; the disease is cutaneous melanoma.